source
- Roche commits up to $1 billion to develop bispecific antibodies with DualitasRoche announced a partnership with Dualitas Therapeutics, a California biotech, to advance bispecific antibody programs aimed at immunological and inflammatory diseases. The agreement includes an…
- Lisata Therapeutics merges with Marea Therapeutics in reverse merger after failed Kuva dealLisata Therapeutics, a solid tumor biotech, announced a stock-for-stock merger with cardiovascular specialist Marea Therapeutics after a previous merger attempt with Kuva Labs collapsed. The trans…